Search Videos and More

Showing 13 - 19 of 19 results

Previous| 1 | 2 |Next


Survival Similar for Younger and Older Patients with Metastatic Colorectal Cancer, Study Finds News

Survival Similar for Younger and Older Patients with Metastatic Colorectal Cancer, Study Finds

Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.
New Research Initiative Launches for All Patients Ever Diagnosed with Colorectal Cancer News

New Research Initiative Launches for All Patients Ever Diagnosed with Colorectal Cancer

Count Me In, a nonprofit cancer research initiative, is inviting all patients across the United States and Canada who have ever been diagnosed with colorectal cancer to participate in research and help drive new discoveries related to this disease.
Vitamin D May Protect Against Young-Onset Colorectal Cancer News

Vitamin D May Protect Against Young-Onset Colorectal Cancer

Consuming higher amounts of Vitamin D – mainly from dietary sources – may help protect against developing young-onset colorectal cancer or precancerous colon polyps, according to the first study to show such an association.
Red Meat Consumption May Promote DNA Damage-associated Mutations in Patients with Colorectal Cancer News

Red Meat Consumption May Promote DNA Damage-associated Mutations in Patients with Colorectal Cancer

Genetic mutations indicative of DNA damage were associated with high red meat consumption and increased cancer-related mortality in patients with colorectal cancer, according to a study led by Dana-Farber Cancer Institute researchers and published in Cancer Discovery, a journal of the American Association for Cancer Research.
“45 is the New 50” as Age for Colorectal Cancer Screening is Lowered News

“45 is the New 50” as Age for Colorectal Cancer Screening is Lowered

Prompted by a recent alarming rise in cases of colorectal cancer in people younger than 50, an independent expert panel has recommended that individuals of average risk for the disease begin screening exams at 45 years of age instead of the traditional 50.
New ‘Druggable’ Genetic Targets Identified in Rare Type of Bile Duct Cancer News

New ‘Druggable’ Genetic Targets Identified in Rare Type of Bile Duct Cancer

Scientists are beginning to make inroads into treating cholangiocarcinoma, a rare, lethal cancer of the bile ducts, with precision drugs. Last year, the first targeted drug for some patients with the disease was approved.
Break Through Cancer Launches Collaborative Model Across Top U.S. Research Institutions in Pursuit of Cancer Cures News

Break Through Cancer Launches Collaborative Model Across Top U.S. Research Institutions in Pursuit of Cancer Cures

Break Through Cancer today announced its formal launch as a public foundation designed to find new solutions to the most intractable challenges in cancer.

Showing 13 - 19 of 19 results

Previous| 1 | 2 |Next